These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20875144)

  • 1. Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.
    Rucklidge JJ; Gately D; Kaplan BJ
    BMC Psychiatry; 2010 Sep; 10():74. PubMed ID: 20875144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of bipolar disorder II and ADHD with a micronutrient formula: a case study.
    Rucklidge JJ; Harrison R
    CNS Spectr; 2010 May; 15(5):289-95. PubMed ID: 20448519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar Disorder in Children With ADHD: A Clinical Sample Study.
    Donfrancesco R; Di Trani M; Andriola E; Leone D; Torrioli MG; Passarelli F; DelBello MP
    J Atten Disord; 2017 Jul; 21(9):715-720. PubMed ID: 25015582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral-Vitamin Treatment Associated with Remission in Attention-Deficit/Hyperactivity Disorder Symptoms and Related Problems: 1-Year Naturalistic Outcomes of a 10-Week Randomized Placebo-Controlled Trial.
    Darling KA; Eggleston MJF; Retallick-Brown H; Rucklidge JJ
    J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):688-704. PubMed ID: 31343273
    [No Abstract]   [Full Text] [Related]  

  • 6. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial.
    Rucklidge JJ; Eggleston MJF; Johnstone JM; Darling K; Frampton CM
    J Child Psychol Psychiatry; 2018 Mar; 59(3):232-246. PubMed ID: 28967099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBCL pediatric bipolar disorder profile and ADHD: comorbidity and quantitative trait loci analysis.
    McGough JJ; Loo SK; McCracken JT; Dang J; Clark S; Nelson SF; Smalley SL
    J Am Acad Child Adolesc Psychiatry; 2008 Oct; 47(10):1151-7. PubMed ID: 18724256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we predict treatment response in children with ADHD to a vitamin-mineral supplement? An investigation into pre-treatment nutrient serum levels, MTHFR status, clinical correlates and demographic variables.
    Rucklidge JJ; Eggleston MJF; Darling KA; Stevens AJ; Kennedy MA; Frampton CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():181-192. PubMed ID: 30217770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study.
    Gordon HA; Rucklidge JJ; Blampied NM; Johnstone JM
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):783-98. PubMed ID: 26682999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBCL-pediatric bipolar disorder phenotype: severe ADHD or bipolar disorder?
    Holtmann M; Goth K; Wöckel L; Poustka F; Bölte S
    J Neural Transm (Vienna); 2008; 115(2):155-61. PubMed ID: 17994189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of youth who manifested the CBCL-Pediatric Bipolar Disorder phenotype during childhood and/or adolescence.
    Meyer SE; Carlson GA; Youngstrom E; Ronsaville DS; Martinez PE; Gold PW; Hakak R; Radke-Yarrow M
    J Affect Disord; 2009 Mar; 113(3):227-35. PubMed ID: 18632161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement.
    Rucklidge JJ; Johnstone J; Gorman B; Boggis A; Frampton CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():163-71. PubMed ID: 24374068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric comorbidity in patients with pediatric bipolar disorder - A systematic review.
    Fahrendorff AM; Pagsberg AK; Kessing LV; Maigaard K
    Acta Psychiatr Scand; 2023 Aug; 148(2):110-132. PubMed ID: 36941106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment.
    Frías Á; Palma C; Farriols N
    J Affect Disord; 2015 Mar; 174():378-89. PubMed ID: 25545605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
    De Bruyckere K; Bushe C; Bartel C; Berggren L; Kan CC; Dittmann RW
    CNS Drugs; 2016 Jun; 30(6):541-58. PubMed ID: 27224994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
    Stein MA; Sikirica V; Weiss MD; Robertson B; Lyne A; Newcorn JH
    CNS Drugs; 2015 Nov; 29(11):953-62. PubMed ID: 26547425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental pathways for different subtypes of early-onset bipolarity in youths.
    Masi G; Mucci M; Pfanner C; Berloffa S; Magazù A; Perugi G
    J Clin Psychiatry; 2012 Oct; 73(10):1335-41. PubMed ID: 23058936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
    Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP
    Encephale; 2005; 31(3):337-48. PubMed ID: 16142049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.